For the first time, we are above the European average in terms of the availability of innovative medicines - this would be the main news from Monday's Access GAP 2026 conference, if it were not for the fact that a huge problem has emerged: the financial crisis of the National Health Fund, which...
On Monday, May 25, the next meeting of the AOTMiT Transparency Council.
Doctors and patients speak with one voice: remission in inflammatory bowel diseases is the therapeutic goal today, and modern drugs are changing the lives of patients - but only those who reach them. And this is still a problem in Poland.
April's reimbursement list brought long-awaited changes for lung cancer patients. Among the new therapies was amivantamab, a novel bispecific antibody reimbursed in two indications for patients with EGFR mutations.
Nusinersen was the first drug used to treat spinal muscular atrophy in Poland, and after seven years of clinical experience it remains a therapy with proven efficacy and safety. - In the majority of patients, we observe not only stabilization of the disease, but also real improvement in...
On Monday, May 18, the next meeting of the Transparency Council.
The introduction of nusinersen has completely changed the prognosis of patients with spinal muscular atrophy, emphasizes Prof. Magdalena Chrościńska-Krawczyk, head of the Department of Pediatric Neurology at the University Children's Hospital in Lublin. Thanks to the therapy, children with the...
The Polish Society of Rheumatology reports that access to innovative treatment for patients with rheumatic diseases in Poland is steadily improving. Due to the complex pathomechanism, heterogeneous clinical picture, co-occurrence of other diseases and individual variation in response to...
Motoneurons are responsible for muscle movement and strength, and their loss is a key problem in SMA. Prof. Anna Kostera-Pruszczyk, head of the Department of Neurology at Warsaw Medical University's UCK WUM Central Clinical Hospital, stresses that modern treatment makes it possible not only to...
On Monday, May 11, the next meeting of the AOTMiT Transparency Council.
On Monday, May 4, the next meeting of the Transparency Council.
His health problems began eight years ago, at the age of 31. However, he never thought it could be something serious. It started with progressive fatigue, weakness, and joint and bone pain. Since he was training extensively in table tennis at the time, he associated these symptoms with training...
- When I first heard about this therapy, I thought we were talking about a trip to Mars. And I absolutely did not even dream that it would be available in our country," recalls Prof. Lidia Gil. Polish patients with plasmocytic myeloma are waiting for access to this therapy.
- Migraine is not just a headache - it's really a lot of suffering that affects the entire brain. It's hypersensitivity to stimuli, difficulty adapting to new and difficult factors, and severe attacks of pain accompanied by nausea, vomiting and hypersensitivity to light, sounds or smells. These...
Peter was born with fish scales and the accompanying Atopic Dermatitis. Today he is eight years old and battles chronic skin disease, itching and flaky skin every day. These symptoms not only affect his comfort, but also his sleep and mood. Proper care and specialized therapeutic clothing play a...
On Monday, April 13, the next meeting of the AOTMiT Transparency Council.
Jaki był powód decyzji?
W poniedziałek 9 marca kolejne posiedzenie Rady Przejrzystości AOTMiT.
The Health Ministry is reviewing the lists of free medicines, including for seniors, but no decisions resulting in the removal of specific preparations have been made, representatives of the ministry assured during a meeting of the Senior Policy Committee, dedicated to, among other things, access...
On Monday, March 2, the next meeting of the AOTMiT Transparency Council.
Drugs for obesity are not reimbursed because regulations do not allow funding for therapies that can be substituted by lifestyle changes, Deputy Minister Katarzyna Kęcka said at Wednesday's meeting of the Health Committee. - Obesity is a biological disease, experts remind.
Aleksander Kwieciński został wybrany na przewodniczącego Rady Nadzorczej INFARMA. Jego kadencja rozpocznie się 1 marca. Doświadczony menedżer branży biofarmaceutycznej zapowiada dalsze działania na rzecz innowacyjnych terapii i rozwiązań zorientowanych na potrzeby pacjentów.
Narodowy Fundusz Zdrowia nie zapłacił szpitalom ponad 2 mld zł za leczenie pacjentów w programach lekowych w 2025 r. Placówki muszą najpierw finansować terapie z własnych środków, a opóźnienia w rozliczeniach obejmują zarówno leczenie onkologiczne, jak i choroby przewlekłe.
On Monday, February 16, the next meeting of the AOTMiT Transparency Council will take place.
The Chief Pharmaceutical Inspector has withdrawn one batch of the medicinal product Loperamid APTEO MED 2 mg from marketing nationwide.
The OJ of the Ministry of Health published an Announcement of the Minister of Health dated February 5, 2026 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland.The current list...
On Monday, February 9, the next meeting of the AOTMiT Transparency Council.
On Tuesday, February 3, the next meeting of the Transparency Council.
On Monday, February 2, the next meeting of the Transparency Council.
Ministerstwo Zdrowia opublikował wykaz produktów leczniczych, które nie podlegają finansowaniu w ramach procedury ratunkowego dostępu do technologii lekowych (RDTL). Resort zdrowia zapewnia, że pacjenci, którzy rozpoczęli leczenie przed wejściem w życie wykazu, zachowują prawo do kontynuacji...
© 2023 Medexpress. All Rights Reserved
